ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Efficacy"

  • 2020 American Transplant Congress

    Efficacy and Safety Outcomes by Donor Type in De Novo Renal Transplant Recipients Receiving Everolimus with Reduced-Dose Calcineurin Inhibitor: 24-Month Results from Transform

    S. Berger1, M. Bakr1, F. Bemelman1, R. Danguilan1, H. De Fijter1, D. Han1, M. Kim1, E. Mor1, A. Patel1, M. Hernandez Gutierrez2, A. Gawai2, Y. Watarai1

    1TRANSFORM Study Group, Basel, Switzerland, 2Novartis Pharma AG, Basel, Switzerland

    *Purpose: To assess the efficacy and safety outcomes in de novo renal transplant (RTx) recipients receiving everolimus with reduced-exposure calcineurin inhibitor (EVR+rCNI) versus mycophenolate with…
  • 2020 American Transplant Congress

    The Learning Curve for Pure Laparoscopic Robotic Kidney Transplantation: An Analysis of Outcomes of the First 80 Consecutive Cases at a High-Volume Transplant Center

    F. Tinney Jr.1, J. Stracke2, T. Ivanics1, A. Elsabbagh1, J. Denny1, D. Kim1, L. Malinzak1, A. Yoshida1

    1Transplant Institute, Henry ford Hospital, Detroit, MI, 2Transplant Surgery, Metro Health Hospital, Wyoming, MI

    *Purpose: Robotic surgery is increasingly used in complex operations, including living-donor kidney transplantation. At this time, knowledge of the number of cases required to attain…
  • 2020 American Transplant Congress

    A Long-Term Follow-Up Study of High-Dose Intravenous Cyclosporine Combined Plasma Exchange in the Treatment of FSGS Recurrence after Renal Transplantation – A Single Center Clinical Experience

    Y. Cui, M. F. Wang, C. C. Wei, J. Y. Wu

    Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

    *Purpose: There was still lack of effective treatment for focal segmental glomerulosclerosis(FSGS)recurrence after renal transplantation. The purpose of this study was to explore the risk…
  • 2020 American Transplant Congress

    The Efficacy and Safety of Ischemia-Free Liver Transplantation (IFLT) in the Treatment of End-Stage Liver Disease in a Prospective, Randomized, Controlled Trial: A Report of the First 25 Cases

    X. He, Z. Guo, Q. Zhao, C. Huang, W. Ju, D. Wang, M. Chen, L. Wu, Y. Ma, Y. Chen, A. Hu, X. Zhu

    Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

    *Purpose: We’ve established a novel procedure called ischemia-free liver transplantation (IFLT). The results from the pilot study suggest that IFLT might prevent ischemia-reperfusion injury (IRI)…
  • 2020 American Transplant Congress

    A Video Education Intervention to Improve Kidney Transplant Knowledge and Willingness to Complete Transplant Evaluation in Dialysis Patients

    D. A. DuBay1, T. A. Morinelli1, Z. Sutton1, M. Chastain1, T. Thompkins Tindal1, Z. Su2, E. Weeda3, P. Mauldin4, M. Casey1, J. Bian2, D. Taber1, P. K. Baliga1

    1Surgery, Division of Transplant Surgery, Medical University of South Carolina`, Charleston, SC, 2General Internal Medicine, Medical University of South Carolina`, Charleston, SC, 3Clinical Pharmacy-Outcomes Sciences, Medical University of South Carolina`, Charleston, SC, 4General Internal Medicine, Medical University of South Carolina, Charleston, SC

    *Purpose: The Centers for Medicare and Medicaid Services has set a goal of 30% (currently 18.5%) of dialysis patients to be on a transplant (Tx)…
  • 2020 American Transplant Congress

    Thymoglobulin for Induction Less is Clearly More!

    N. Patel, P. Nicole

    -, -, SC

    *Purpose: The ideal total dose of anti-thymocyte globulin (ATG) is unknown in the African American (AA) kidney transplant population.The purpose of this study was to…
  • 2020 American Transplant Congress

    Effect of Therapeutic Plasma Exchange on Glomerular Filtration Rate in Patients with Acute Humoral Rejection

    M. Maza Moreno, S. Hernandez-Estrada, J. Cano Cervantes, D. Maldonado Tapia, M. Alamilla Sanchez

    Nephrology and Transplant Division, CMN 20 de Noviembre, Ciudad de Mexico, Mexico

    *Purpose: AMR is the main risk factor for graft loss, especially after the first post transplant year. Up to 80% of patients achieve response with…
  • 2020 American Transplant Congress

    Assessment of Time to Therapeutic Tacrolimus Levels Following Renal Transplantation in a Non-Weight-Based Dosing Model

    J. Banbury1, A. Dodson1, C. Lin2, K. Gutierrez1

    1University of Alabama at Birmingham Hospital, Birmingham, AL, 2Center for Clinical and Translational Science, University of Alabama at Birmingham, Birmingham, AL

    *Purpose: The optimal initial dose for tacrolimus (TAC) after renal transplant (RT) remains controversial with limited evidence comparing weight-based and conservative strategies. Recent literature suggests…
  • 2020 American Transplant Congress

    Safety and Efficacy of Endoscopic Transpapillary Gallbladder Stenting for Symptomatic Gallbladder Disease in Cirrhosis: A Systematic Review and Meta-Analysis

    K. F. Haq1, U. Iqbal2, M. Khan3, F. Kamal4, S. Solanki5, R. Chakinala5, M. Siddiqui1, M. Abu Ghanimeh1, O. Sadiq1, A. Watson1, T. Zuchelli1, R. Salgia1

    1Gastroenterology & Hepatology, Henry Ford Hospital, Detroit, MI, 2Medicine, Geisinger Medical Center, Danville, PA, 3Gastroenterology & Hepatology, University of Alabama, Birmingham, AL, 4Gastroenterology & Hepatology, University of Tennessee, Knoxville, TN, 5Medicine, Guthrie Hospital, Sayre, PA

    *Purpose: Endoscopic transpapillary gallbladder (cystic duct) stenting has been shown to be an effective treatment option for symptomatic gallbladder disease in patients with cirrhosis. However,…
  • 2020 American Transplant Congress

    Single-Dose Pre-Operative Pregabalin to Minimize Pain and Opioid Use after Liver Transplantation

    J. P. Knorr, A. Barlow, T. Reinaker, R. Zaki

    Einstein Medical Center Philadelphia, Philadelphia, PA

    *Purpose: Multimodal pain management strategies, including pregabalin (PGB) alone, have demonstrated efficacy in minimizing post-surgical pain and opioid use. Our study aimed to determine if…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 14
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences